SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-097031
Filing Date
2023-12-19
Accepted
2023-12-19 17:28:31
Documents
1
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3966
  Complete submission text file 0001213900-23-097031.txt   5464
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 305 WEST 18TH STREET, APT 4B NEW YORK NY 10011
Business Address
Shenouda Maged (Reporting) CIK: 0001658369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 231498622